Sea Otter Advisors »

Revance Therapeutics shares owned by Sea Otter Advisors

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Sea Otter Advisors from 13F filings

Historical chart of Sea Otter Advisors investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Sea Otter Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Sea Otter Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $62k 7.0k 8.79

More positions owned by Sea Otter Advisors

Occidental Pete Corp *w Exp 080327 (OXY.WS)
Spdr S&p 500 Etf Put Option (SPY)
Sirius Xm Holdings Call Option (SIRI)
Liberty SiriusXM Group A (LSXMA)
Tesla Motors Call Option (TSLA)
Gigcapital 5
Kayne Anderson MLP Investment (KYN)
Blueriver Acquisition Corp Cl A Ord Cl A Ord Shs (BLUA)
Welsbach Tech Metals Acqu (WTMA)
Tlgy Acquisition Corporation (TLGY)
Cushing Mlp & Infrastruct Com New cef (SRV)
Israel Acquisitions Corp Class A Ord Class A Ord (ISRL)
Acri Capital Acquisition Corp Com Cl A Com Cl A (ACAC)
Tortoise Energy Infrastructure closed end funds (TYG)
Concord Acquisition Corp Iii Com Cl A Com Cl A

View all positions for Sea Otter Advisors

Top funds holding Revance Therapeutics

Palo Alto Investors
Vanguard Group
Franklin Resources
Jpmorgan Chase & Co
Bamco
Walleye Trading Advisors
Goldman Sachs Group
Rice Hall James & Associates
Charles Schwab Investment Management
Citadel Advisors
Wellington Management Company
D. E. Shaw & Co
HighTower Advisors
Balyasny Asset Management
Barclays

View all funds holding Revance Therapeutics